Ligand validation:3RI5

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3RI5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RI5_NAG_C_400	28%	40%	0.192	0.843	0.37	1.92	-	2	1	0	100%	0.9333
3RI5_NAG_E_400	5%	50%	0.324	0.742	0.49	1.42	-	4	0	0	100%	0.9333
3RI5_NAG_B_400	4%	61%	0.477	0.847	0.52	0.97	-	2	1	0	100%	0.9333
4TNV_NAG_E_401	53%	75%	0.14	0.899	0.33	0.63	-	-	0	0	100%	0.9333
4TNW_NAG_E_401	46%	78%	0.163	0.897	0.26	0.63	-	-	0	0	100%	0.9333
3RIF_NAG_E_400	8%	56%	0.35	0.817	0.46	1.2	-	2	0	0	100%	0.9333
3RHW_NAG_B_400	5%	41%	0.384	0.791	0.57	1.7	-	3	1	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.